Episode 065: Breast Cancer Series, Pt. 10-ER+, Metastatic Breast Cancer
The Fellow on Call: The Heme/Onc Podcast
00:00
Antibody–Drug Conjugates and Chemotherapy Choices
Evidence for trastuzumab deruxtecan in HER2‑low (DESTINY‑Breast), sacituzumab govitecan for heavily pretreated HR+ disease, and practical single-agent chemotherapy options including capecitabine dosing.
Play episode from 28:12
Transcript
